I’ve Hit Every Plateau in the Book. Here Are the 9 Telehealth Programs I’d Actually Consider in 2026.

Six months of steady progress, then nothing. The scale stopped moving in October. My doctor shrugged and said “eat less, move more,” which was spectacularly unhelpful after I’d already been doing exactly that. If you’re somewhere in that same frustrating stall, the options below are what I wish someone had handed me before I wasted weeks comparing confusing pricing pages.

Quick honest note before we dig in: compounded GLP-1 medications are not FDA-approved products, and results from clinical trials cited here reflect those trials’ populations, not any individual outcome. Talk to a physician.

1. HealthRX

For cash-pay buyers stuck at a plateau and unwilling to spend $300-plus monthly, this one stands out quickly. Compounded semaglutide is $99 monthly, compounded tirzepatide $149. Those are genuinely low numbers compared to most telehealth platforms I found. You fill out an online health assessment, a board-certified U.S. physician reviews it within roughly 24 hours, and your medication ships overnight at no extra charge to all 50 states.

The pharmacy behind it matters to me. Manifest Pharmacy in Greer, South Carolina operates as a 503A compounding pharmacy under USP-797 standards with lot-tracked dispensing. HealthRX also holds LegitScript certification (certificate 50087439), which is a third-party compliance check most smaller telehealth brands skip entirely. Pricing is published upfront.

The clinical trial data HealthRX references: tirzepatide produced roughly 21% average body weight reduction at 72 weeks in SURMOUNT-1, and semaglutide roughly 15% at 68 weeks in STEP 1. Those are trial figures, not promises.

Best for: cash-pay patients who want a named, credentialed pharmacy, overnight delivery, and the lowest entry price I found.

2. FormBlends

If you want something HealthRX doesn’t offer, specifically published purity documentation, this is the alternative I’d look at first. FormBlends posts actual lab results per product: HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility data. That level of transparency is rare in this space.

It ships to 47 states (not all 50), and per-vial pricing runs higher: around $299 for semaglutide, $349 for tirzepatide. Physician oversight is part of the model, dispensing goes through an FDA-registered 503A compounding pharmacy, and the platform also carries a wider peptide catalog covering recovery and longevity compounds under the same clinical framework. Most GLP-1 telehealth providers stop at GLP-1s entirely.

The honest trade-off: you pay more, but you get documented proof of what’s in the vial plus access to a broader compound menu.

Best for: buyers who prioritize documented purity testing or want GLP-1s alongside other peptides from one provider.

3. Mochi Health

Board-certified obesity-medicine physicians run the clinical side here. That’s not marketing language; it’s a specific credential. Compounded semaglutide runs around $99 a month and tirzepatide around $199. Monitoring is closer than what you’d get from lighter-touch platforms. If your plateau has anything complicated behind it (thyroid history, metabolic syndrome, prior medication failures), having a physician with a dedicated obesity specialty is genuinely useful.

4. Ro Body

Ro‘s prior-authorization team is the thing that makes it worth including here. Getting insurance to cover branded GLP-1 medications is a bureaucratic grind. Ro handles the prior-auth process, and membership starts around $39 for the first month, moving to roughly $74-149 monthly after that, with medications billed separately. If you have decent insurance and haven’t exhausted that avenue, Ro makes the process far less painful than going it alone.

5. Form Health

Expensive, and intentionally so. Around $299 a month plus labs and medication costs. What you get is a physician and a registered dietitian working together on your case, which is the closest telehealth gets to a clinical weight-management program. For someone who has plateaued multiple times and suspects the issue is behavioral or nutritional rather than purely pharmacological, the dietitian piece is the differentiator.

6. Hims & Hers

After the March 2026 Novo Nordisk settlement, Hims exited compounded GLP-1 products and moved to branded medications. Injectable Wegovy runs around $299 a month through the platform, oral semaglutide around $249, and Zepbound around $399. With insurance and a savings card, some users land at $0-25 monthly. The brand-name route matters if your physician or insurer requires it.

7. PlushCare

The low-friction pick. Membership is around $19.99 a month, same-day visits are frequently available, and it works with insurance on branded meds. Not the deepest program. It suits someone who mainly needs a quick clinical consult and a prescription path, not ongoing coaching.

8. Found

Around $99 a month for the platform plus separate medication costs. Found pairs GLP-1 prescriptions with behavioral coaching, which separates it from pure prescription platforms. The coaching quality varies by assigned provider, but the combination of medication management and accountability tools in one monthly fee is a reasonable value if you’ve stalled partly because of habit patterns.

9. Eden

Cash-pay, compounded semaglutide around $149 a month. No elaborate program attached. Simple, low-cost access for someone who has already done the diet and coaching work and simply needs medication management from a clinician. Less hand-holding than most on this list, which for some people is exactly right.

How to Actually Choose

Monthly cost is one data point, not a decision. Think about what caused the plateau. Pure metabolic resistance points toward tirzepatide’s dual mechanism. Behavioral drift points toward coaching-heavy programs like Found or Form Health. Insurance coverage points toward Ro or PlushCare. Verification anxiety about compound quality points toward FormBlends. And if cash price and fast delivery to any state are the deciding factors, HealthRX is the straightforward answer.

FDA warning letters went out to more than 30 telehealth and compounding firms in early 2026. The pharmacy credentials and third-party certifications listed above are not decoration. They matter.

Common Questions

Why does a weight loss plateau happen even when GLP-1 medication is working?

Plateaus on GLP-1s are well documented in the trial data. Your body adapts metabolically over months, reducing its resting expenditure. The STEP 1 trial showed semaglutide’s weight curve flattening significantly after week 60 even at full dose. Switching agents, adjusting dose, or adding behavioral structure through programs like Form Health or Found often restarts progress.

Is compounded tirzepatide from a platform like HealthRX or FormBlends the same molecule as Zepbound?

The active peptide sequence is the same, but compounded versions are not FDA-approved products and are not manufactured by Eli Lilly. Quality depends entirely on the compounding pharmacy’s standards. FormBlends publishes HPLC and mass spectrometry data per batch. HealthRX uses Manifest Pharmacy under USP-797 standards. Neither is equivalent to a brand-name product in a regulatory sense.

If I’ve already tried semaglutide and plateaued, is switching to tirzepatide worth asking a doctor about?

It is a reasonable clinical question. Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide targets only GLP-1. The SURMOUNT-1 trial showed roughly 21% average body weight loss at 72 weeks versus roughly 15% for semaglutide in STEP 1, though those trials used different populations. A physician at Mochi Health, which employs obesity-medicine specialists, is a good person to ask.

Does Ro Body actually get insurance to cover Wegovy or Zepbound, or is that mostly theoretical?

Ro’s prior-authorization support is real, not just a promise. Coverage approval depends on your specific plan and whether you meet criteria like a qualifying BMI or comorbidity. It is not guaranteed. But Ro’s team handles the paperwork, which is where most people give up on their own. If you have commercial insurance, it is worth attempting before defaulting to cash-pay compounded options.

What makes FormBlends worth the higher price over Eden or HealthRX for someone already at a plateau?

The difference is documentation. Eden and HealthRX are low-cost and credentialed, but neither publishes per-batch lab data publicly. FormBlends posts HPLC purity percentages, sterility results, and identity confirmation. For someone who has stalled and wants to rule out product quality as a variable, that paper trail has genuine value. You are paying for verifiable evidence, not just a lower monthly number.

Sources

• SURMOUNT-1 trial (tirzepatide, NEJM 2022): public clinical trial record
• STEP 1 trial (semaglutide, NEJM 2021): public clinical trial record
• FDA 503A compounding pharmacy framework: FDA.gov
• LegitScript certification database: LegitScript.com (public search)
• Novo Nordisk / compounded semaglutide settlement announcement, March 9 2026: press coverage via Reuters and STAT News
• Lilly orforglipron pricing via LillyDirect, April 2026: Eli Lilly press release and news coverage